ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
  • Artikel  (1)
  • 2015-2019  (1)
Sammlung
  • Artikel  (1)
Verlag/Herausgeber
Erscheinungszeitraum
  • 2015-2019  (1)
Jahr
Zeitschrift
Thema
  • 1
    Publikationsdatum: 2015-02-18
    Beschreibung: The NF-B is found in almost all animal cell types and is involved in a myriad of cellular responses. Aberrant expression of NF-B has been linked to cancer, inflammatory diseases and improper development. Little is known about transcriptional regulation of the NF-B family member gene RelA/p65 . Sp1 plays a key role in the expression of the RelA/p65 gene. ZBTB2 represses transcription of the gene by inhibiting Sp1 binding to a Sp1-binding GC-box in the RelA/p65 proximal promoter (bp, –31 to –21). Moreover, recent studies revealed that RelA/p65 directly binds to the peroxisome proliferator-activated receptor- coactivator1α (PGC1α) to decrease transcriptional activation of the PGC1α target gene PDK4 , whose gene product inhibits pyruvate dehydrogenase (PDH), a key regulator of TCA cycle flux. Accordingly, we observed that RelA/p65 repression by ZBTB2 indirectly results in increased PDK4 expression, which inhibits PDH. Consequently, in cells with ectopic ZBTB2, the concentrations of pyruvate and lactate were higher than those in normal cells, indicating changes in glucose metabolism flux favoring glycolysis over the TCA cycle. Knockdown of ZBTB2 in mouse xenografts decreased tumor growth. ZBTB2 may increase cell proliferation by reprogramming glucose metabolic pathways to favor glycolysis by upregulating PDK4 expression via repression of RelA/p65 expression.
    Print ISSN: 0305-1048
    Digitale ISSN: 1362-4962
    Thema: Biologie
    Publiziert von Oxford University Press
    Standort Signatur Erwartet Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...